Aldeyra Therapeutics, Inc (ALDX) Stock Price

5.23 ▲ +0.27 (+5.44%)
Open: 4.97 Vol: 864.66K Day's range: 4.95 - 5.30 Nov 24, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALDX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 5.23▼ 5.21▲ 5.21▲ 4.94▲ 5.00▲
MA10 5.22▲ 5.20▲ 5.14▲ 5.02▲ 5.17▲
MA20 5.21▲ 5.13▲ 5.00▲ 5.01▲ 5.26▼
MA50 5.21▲ 4.96▲ 4.98▲ 5.17▲ 4.66▲
MA100 5.15▲ 4.99▲ 4.98▲ 5.25▼ 4.47▲
MA200 5.00▲ 4.99▲ 5.11▲ 4.61▲ 5.20▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ 0.001▲ 0.033▲ 0.015▲ -0.057▼
RSI 58.552▲ 67.041▲ 68.070▲ 54.152▲ 53.939▲
STOCH 90.572▲ 49.265     80.497▲ 44.008     34.521    
WILL %R -38.462     -18.310▲ -10.924▲ -14.545▲ -57.273    
CCI 120.760▲ 84.911     88.487     95.938     -30.361    
Latest Filters Detected On ALDX
▲ RSI&VOL $ALDX RSI Cross Up and Volume Set Alert
RSI $ALDX RSI(14) Crossed Above 50 Set Alert
▲ MACD $ALDX MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $ALDX Price Crossed Above MA(50) Set Alert
MA $ALDX Price Crossed Above MA(26) Set Alert
MA $ALDX Price Crossed Above MA(13) Set Alert
Aldeyra Therapeutics, Inc News
Aldeyra Therapeutics Announces Expansion of RASP Platform to Include Central Nervous System Diseases and Provides Updates on Reproxalap at Research & Development Webcast
Thursday, November 13, 2025 04:13 AM
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced at a ...
Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
Monday, November 10, 2025 10:02 PM
Detailed price information for Aldeyra Therapeu (ALDX-Q) from The Globe and Mail including charting and trades.
Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules
Tuesday, October 28, 2025 04:01 AM
Relative to Baseline, Signal-Finding Molecule ADX‑629 Demonstrated Statistically Significant Improvement in Liver Function in Patients with Alcohol-Associated Hepatitis RASP Modulator Product ...
ALDX historical stock data
date open high low close volume
24/11/25 4.97 5.30 4.95 5.23 864,658
21/11/25 4.71 5.065 4.695 4.96 647,708
20/11/25 4.99 5.04 4.71 4.73 560,401
19/11/25 4.89 4.93 4.725 4.86 504,589
18/11/25 4.95 4.99 4.795 4.91 613,033
17/11/25 5.05 5.135 4.85 4.95 622,206
14/11/25 4.94 5.185 4.92 5.05 580,270
13/11/25 5.27 5.27 4.985 5.02 705,503
12/11/25 5.21 5.35 5.18 5.30 857,999
11/11/25 5.13 5.285 5.00 5.23 526,358
Quote Details
52wk Low:1.14
52wk High:7.20
Vol:864.66K
Avg Vol(3m):14.2M
1Y Chng:-1.13%
1M Chng:-2.06%
Add to Watch List
More Information
Index US Composite
Market Cap. 298.41M